Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07116889 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
A Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease), sponsored by Generate Biomedicines.
- Active
- Registry status
- Phase 1
- Development phase
- 156
- Enrollment target
- 13
- Study locations
NCT07116889 is a Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease) that is active but no longer recruiting, run by Generate Biomedicines. The registered enrollment target is 156 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The trial reports 13 study locations across 5 states.
The verdict
NCT07116889, a Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease), is active but no longer recruiting, sponsored by Generate Biomedicines.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 156 participants
- Enrollment target
- 13
- Study locations
Study Summary
This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
Conditions Studied
Interventions
- BIOLOGICAL GB-0895 (SC)
- DRUG Placebo (SC)
Study Locations (13)
Other
- Charite Research Organization GmbH - Berlin
- IKF Pneumologie - Frankfurt
- Fraunhofer Institut fur Toxikologie and Experimentelle Medizin (ITEM) - Hanover
- Hammersmith Medicines Research - London
- Queen Anne Street Medical Center - London
- Medicines Evaluation Unit (MEU) - Manchester
- Simbec-Orion Clinical Development - Merthyr Tydfil
Florida
- Alcanza - DeLand
- Miami Research Institute of South Florida - Miami
- Omega Research - Orlando
Minnesota
- Nucleus Network - Saint Paul
North Carolina
- Southeastern Research Center - Winston-Salem
Texas
- DM Clinical Research - Tomball
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2023-12-12 |
| Est. Completion | 2027-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07116889
The ClinicalTrials.gov registry entry for NCT07116889 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The listed sponsor is Generate Biomedicines, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which GB-0895 (SC) is the first listed.
NCT07116889 reports 13 study locations spanning 5 distinct geographic areas - top geographies include Other, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07116889 about?
NCT07116889 is a clinical study titled "A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD". This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
What is the current status of trial NCT07116889?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 156 participants. The study started on 2023-12-12. Estimated completion is 2027-05.
What conditions does trial NCT07116889 study?
This clinical trial studies the following conditions: Asthma, COPD (Chronic Obstructive Pulmonary Disease).
What interventions are being tested in trial NCT07116889?
The interventions under investigation include: GB-0895 (SC) (BIOLOGICAL), Placebo (SC) (DRUG).
Who is sponsoring clinical trial NCT07116889?
This trial is sponsored by Generate Biomedicines, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07116889 being conducted?
This trial has 13 study locations across Florida, Minnesota, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
RECRUITING · Phase 1
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
RECRUITING · Phase 1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
ACTIVE NOT RECRUITING · Phase 1
-
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.